Pasar al contenido principal

CONTRIBUCION MOLECULAR DE HELICASAS DE RNA Y PROTEINAS RIBOSOMICAS AL ENSAMBLAJE DEL RIBOSOMA EUCARIOTICO Y SUS CONSECUENCIAS EN EL PROCESO DE TRADUCCION

PID2022-136564NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Beak of Eukaryotic Ribosomes: Life, Work and Miracles

  • Martín-Villanueva, Sara
  • Galmozzi, Carla V.
  • Ruger-Herreros, Carmen
  • Kressler, Dieter
  • Cruz, Jesús de la
Ribosomes are not totally globular machines. Instead, they comprise prominent structural protrusions and a myriad of tentacle-like projections, which are frequently made up of ribosomal RNA expansion segments and N- or C-terminal extensions of ribosomal proteins. This is more evident in higher eukaryotic ribosomes. One of the most characteristic protrusions, present in small ribosomal subunits in all three domains of life, is the so-called beak, which is relevant for the function and regulation of the ribosome's activities. During evolution, the beak has transitioned from an all ribosomal RNA structure (helix h33 in 16S rRNA) in bacteria, to an arrangement formed by three ribosomal proteins, eS10, eS12 and eS31, and a smaller h33 ribosomal RNA in eukaryotes. In this review, we describe the different structural and functional properties of the eukaryotic beak. We discuss the state-of-the-art concerning its composition and functional significance, including other processes apparently not related to translation, and the dynamics of its assembly in yeast and human cells. Moreover, we outline the current view about the relevance of the beak's components in human diseases, especially in ribosomopathies and cancer., This publication is part of the project R+D+i PID2022-136564NB-I00 funded by MCIN/AEI/10.13039/501100011033/ERDF, EU to J.d.l.C. We also acknowledge the Andalusian Platform for Biomodels and Resources in Genomic Edition, the Fortalece Program (FORT 2023) from MCIN, and the Translacore (CA21154) and ProteoCure (CA20113) COST Actions from the EU for support. D. K. is supported by the Swiss National Science Foundation (project grant 310030_204801). S.M.-V. was an academic research staff member of the Andalusian Research, Development, and Innovation Plan by the Andalusian Regional Government (PAIDI 2020). C.V.G. was supported by a Marie Sklodowska-Curie Individual Fellowship (H2020-MSCA-IF-2020, Grant 101024158 from the EU). C.R.-H. is supported by a María Zambrano Grant from the Spanish Ministry of Universities., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sorafenib-associated translation reprogramming in hepatocellular carcinoma cells

  • Contreras, Laura
  • Rodríguez-Gil, Alfonso
  • Muntané, Jordi
  • Cruz, Jesús de la
Sorafenib (Sfb) is a multikinase inhibitor regularly used for the management of patients with advanced hepatocellular carcinoma (HCC) that has been shown to increase very modestly life expectancy. We have shown that Sfb inhibits protein synthesis at the level of initiation in cancer cells. However, the global snapshot of mRNA translation following Sorafenib-treatment has not been explored so far. In this study, we performed a genome-wide polysome profiling analysis in Sfb-treated HCC cells and demonstrated that, despite global translation repression, a set of different genes remain efficiently translated or are even translationally induced. We reveal that, in response to Sfb inhibition, translation is tuned, which strongly correlates with the presence of established mRNA cis-acting elements and the corresponding protein factors that recognize them, including DAP5 and ARE-binding proteins. At the level of biological processes, Sfb leads to the translational down-regulation of key cellular activities, such as those related to the mitochondrial metabolism and the collagen synthesis, and the translational up-regulation of pathways associated with the adaptation and survival of cells in response to the Sfb-induced stress. Our findings indicate that Sfb induces an adaptive reprogramming of translation and provides valuable information that can facilitate the analysis of other drugs for the development of novel combined treatment strategies based on Sfb therapy., This article is based upon work from COST action CA21154 TRANSLACORE supported by COST (European Cooperation in Science and Technology). It is also part of the project R+D+i PID2022-136564NB-I00 funded by MCIN/AEI/10.13039/501100011033 and ERDF/EU “A way of making Europe” to J.d.l.C, who also acknowledges the Andalusian Platform of Biomodels and Resources in Genomic Edition, and the FORTALECE Program (FORT23/00008) from MCIN. J.M. is supported by the Instituto de Salud Carlos III, ISCIII (PI16/00090 and PI19/01266), and the Consejería de Salud y Familias (PI-0216–2000) of the Andalusian Government. We also thank the Biomedical Research Network Center for Liver and Digestive Diseases (CIBEREHD) funded by ISCIII and co-financed by ERDF “A way to achieve Europe). L.C. was a recipient of an FPU contract from the Spanish Ministry (FPU16/05127). A.R.-G. was funded by CIBERONC (CB16/12/00480) and the Andalusian Regional Government, University of Seville, and ERDF (US-1380874)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Regulation of transcription elongation anticipates alternative gene expression strategies across the cell cycle

  • Maya-Miles, Douglas
  • García-Martínez, José
  • Cases, Ildefonso
  • Pasión, Rocío
  • Cruz, Jesús de la
  • Pérez-Ortín, José Enrique
  • Muñoz-Centeno, Mari Cruz
  • Chávez, Sebastián
A growing body of evidence supports the idea that RNA polymerase II (RNAP II) activity during transcription elongation can be regulated to control transcription rates. Using genomic run-on and RNAP II chromatin immunoprecipitation, we measured both active and total RNAP II across the bodies of genes at three different stages of the mitotic cell cycle in Saccharomyces cerevisiae: G1, S, and G2/M. Comparison of active and total RNAP II levels at these stages revealed distinct patterns of transcription elongation control throughout the cell cycle. Previously characterized cycling genes were associated with some of these elongation patterns. A cluster of genes with highly divergent genomic run-on and RNAP II chromatin immunoprecipitation patterns was notably enriched in genes related to ribosome biogenesis and the structural components of the ribosome. We confirmed that the expression of ribosome biogenesis mRNAs increases after G1 but decreases following mitosis. Finally, we analyzed the contribution of mRNA stability to each cluster and found that a coordinated regulation of RNAP II activity and mRNA decay is necessary to fully understand the alternative strategies of gene expression across the cell cycle., This work was supported by grants PID2020-112853GB-C31 to JEP-O, PID2022-136564NB-I00 to JdlC, and PID2023-148037NB-C21 to SC and MCM-C, funded by MICIU/AEI/10.13039/501100011033/ERDF, EU, and CIAICO/2022/237 funded by Generalitat Valenciana to JEP-O., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The DExD-box RNA helicase Dbp7 unwinds short double-stranded RNAs

  • Contreras, Julia
  • Capeyrou, Régine
  • Henry, Yves
  • Henras, Anthony K.
  • Humbert, Odile
  • Cruz, Jesús de la
  • Villalobo, Eduardo
DExD-box proteins are ATP-dependent enzymes that unwind double-stranded RNAs in a non-processive manner, often initiating strand separation from 5′- or 3′-single-stranded overhangs. Dbp7, a member of this family, is required for yeast ribosome biogenesis and has been specifically implicated in the release of the small nucleolar RNA snR190 from early pre-60S particles. To gain mechanistic insight into its function, we have examined the in vitro helicase activity of recombinant Dbp7. We show that it efficiently unwinds short double-stranded RNA substrates in an ATP-dependent manner, irrespective of overhang polarity, thereby establishing it as a bona fide DExD-box RNA helicase., This publication was in part funded by project R+D+i PID2022-136564NB-I00 granted by MICIU/AEI/10.13039/501100011033 and ERDF/UE "A way of making Europe" to J.d.l.C. This research was also funded by ANR (ANR-20-CE12-0026), CNRS and University of Toulouse, France., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The many ways to inhibit translation by Sorafenib in liver cancer cells

  • Contreras Bernal, Laura
  • Ricciardi, Sara
  • Biffo, Stefano
  • Muntané, Jordi
  • Cruz, Jesús de la
Sorafenib targets various tyrosine kinase receptors, inhibiting cell growth and proliferation, angiogenesis and metastasis in tumour cells. It is used to treat certain types of cancers including renal, thyroid and liver (hepatocellular carcinoma) cancers. Although Sorafenib is approved for advanced hepatocellular carcinoma, it only extends patient´s lives by a few months, highlighting the urgent need to better understand how it works and to develop more effective treatments. Sorafenib specifically inhibits translation initiation in hepatocellular carcinoma cells. Herein, we revealed that this inhibition results, at least, from the activation of PERK, triggering a stress response that leads to eIF2α phosphorylation, the inhibition of MNK1a-signalling-dependent eIF4E phosphorylation, and the aberrant assembly of the canonical eIF4F complex. Sorafenib also inhibits the ERK1/2 MAPK signalling in HepG2 cells. However, the mTORC1 pathway does appear to play a pivotal role in Sorafenib-dependent translation inhibition, as revealed by the phosphorylation levels of RPS6 and 4EBP1 proteins and the effects on translation of gene silencing 4EBP1/2 in Sorafenib-treated cells. Translation inhibition correlates with reduced production of cancer-promoting proteins like Cyclin D1 and c-Myc. Overexpression of the phosphomimetic eIF4E-S209D variant, which constitutively activates eIF4E, shows that inhibition of eIF4E phosphorylation directly causes Cyclin D1 down-regulation and cell-cycle delay in Sorafenib-treated cells. Taken together, our results confirm that Sorafenib induces translation reprogramming, whose understanding is crucial for improving its efficacy as a cancer therapy., Funding for open access publishing: Universidad de Sevilla/CBUA. This work was supported by the project R + D + i PID2022-136564NB-I00 funded by MCIN/AEI/https://doi.org/10.13039/501100011033 and ERDF/UE "A way of making Europe" to J.d.l.C, who also acknowledges the Andalusian Platform of Biomodels and Resources in Genomic Edition, the FORTALECE Program (FORT 2023) from MCIN, and the Translacore (CA21154) and ProteoCure (CA20113) COST Actions from the EU (European Cooperation in Science and Technology) for support. This research was also funded by grant PRIN02020EK82R5 to S.B. J.M. is supported by the Instituto de Salud Carlos III, ISCIII (PI16/00090 and PI19/01266), and the Consejería de Salud y Familias (PI-0216–2020) of the Andalusian Government. We also thank the Biomedical Research Network Center for Liver and Digestive Diseases (CIBEREHD) funded by ISCIII and co-financed by ERDF "A way to achieve Europe). L.C. was a recipient of an FPU contract from the Spanish Ministry (FPU16/05127)., Peer reviewed